Achieve Perfection in Research
APExBIO (apexbt.com) scores 77 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Manufacturing brands, Other brands, in the 53rd percentile of 8387 Healthcare brands.
APExBIO is a life science reagent supplier that provides small molecule inhibitors, mRNA synthesis reagents, compound libraries, peptides, and assay kits. The company's mission is to accelerate research in cancer, immunology, and epigenetics by supplying high-quality tools to scientists. Its customers include academic researchers, biotechnology firms, and pharmaceutical companies working in these therapeutic and research areas. APExBIO positions itself as a trusted, quality-focused supplier supporting biomedical research worldwide.
| Brand Name | APExBIO |
|---|---|
| Domain | apexbt.com |
| Industry | Healthcare, Manufacturing |
| Main Competitors | MedChemExpress (82/100), Selleck Chemicals (75/100), Cayman Chemical (70/100), Tocris Bioscience (77/100), MilliporeSigma (83/100), Abcam (85/100), Enzo Life Sciences (81/100), MedKoo Biosciences |
Moz Domain Authority 30/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #360,677 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "APExBIO provides Small Molecule Inhibitors, mRNA synthesis reagents, Compound Libraries, Peptides and Assay Kits that accelerate cancer, immunology and epigenetics research worldwi…" (Meta description: 22 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, GitHub; no detected presence on YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is APExBIO?", Claude could identify the brand as of September 2026. ApexBio (ApexBT.com) is a life science company that manufactures and sells biochemicals, small molecule inhibitors, agonists, antagonists, and compound screening libraries for biomedical research. Best known for Supplying research-grade small molecule inhibitors and compound libraries for drug discovery and biological research.
When asked "Best brands similar to APExBIO?", Claude would recommend APExBIO as of September 2026. It's a legitimate and commonly used supplier in the research chemical space, often mentioned alongside companies like Selleck Chemicals and MedChemExpress for sourcing lab compounds.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
APExBIO's main competitors in Healthcare: MedChemExpress (82/100), Selleck Chemicals (75/100), Cayman Chemical (70/100), Tocris Bioscience (77/100), MilliporeSigma (83/100).
Sources: Brand Analyzer scan
APExBIO offers small molecule inhibitors, mRNA synthesis reagents, compound libraries, peptides, and assay kits for use in cancer, immunology, and epigenetics research.
Sources: APExBIO official site
APExBIO has low AI-search visibility, scoring 18/100 on Brand Analyzer's AI visibility composite (visibility 5, trust 19, recommendation 41). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: APExBIO official site
APExBIO scores 41/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: APExBIO official site
APExBIO is a supplier of life science research reagents, including small molecule inhibitors, mRNA synthesis reagents, compound libraries, peptides, and assay kits, aimed at supporting biomedical research.
Sources: APExBIO official site
APExBIO manufactures and supplies small molecule inhibitors, mRNA synthesis reagents, compound libraries, peptides, and assay kits designed to accelerate research in cancer, immunology, and epigenetics.
Sources: APExBIO official site
APExBIO can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: APExBIO official site
APExBIO's products are used by academic researchers, biotechnology companies, and pharmaceutical companies conducting research in cancer, immunology, and epigenetics.
Sources: APExBIO official site
APExBIO is known for providing a broad portfolio of research reagents-particularly small molecule inhibitors and compound libraries-used to support studies in cancer, immunology, and epigenetics.
Sources: APExBIO official site
APExBIO scores 18/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
APExBIO has a weak AI-visibility profile at 18/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (41/100) and its weakest is visibility (5/100). It benefits from a global traffic rank of #360,677 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 30/100. In a live check, Claude could already identify APExBIO from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to APExBIO: A&D Medical (77/100), American Laser Med Spa (77/100), Arctoris (77/100), Alexandria Real Estate Equities (Alexandria®) (77/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), ZOLL Data Systems (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.